Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-023436
Filing Date
2025-02-19
Accepted
2025-02-19 18:00:05
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4803
  Complete submission text file 0000950170-25-023436.txt   6929
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Issuer) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605 44 7557 251 563
Apeiron Investment Group Ltd. (Reporting) CIK: 0001845711 (see all company filings)

State of Incorp.: O1 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 25642151

Mailing Address BLOCK A, APT.12 IL-PIAZZETTA, TOWER ROAD SLIEMA O1 SLM1605
Business Address
Angermayer Christian (Reporting) CIK: 0001845872 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40493 | Film No.: 25642150